0001666071-20-000242.txt : 20200813
0001666071-20-000242.hdr.sgml : 20200813
20200813191522
ACCESSION NUMBER: 0001666071-20-000242
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200811
FILED AS OF DATE: 20200813
DATE AS OF CHANGE: 20200813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans David Thomas
CENTRAL INDEX KEY: 0001730451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 201100782
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_159736050594990.xml
FORM 4
X0306
4
2020-08-11
0
0001666071
Cardlytics, Inc.
CDLX
0001730451
Evans David Thomas
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
0
1
0
0
Chief Administrative Officer
Common Stock
2020-08-11
4
M
0
208
0
A
12987
D
Common Stock
2020-08-11
4
M
0
741
20
A
13728
D
Common Stock
2020-08-11
4
M
0
700
30.44
A
14428
D
Common Stock
2020-08-11
4
M
0
700
20
A
15128
D
Common Stock
2020-08-11
4
S
0
13019
75.55
D
2109
D
Common Stock
2020-08-11
4
S
0
401
76.05
D
1708
D
Common Stock
2020-08-12
4
M
0
5509
20
A
7217
D
Common Stock
2020-08-12
4
M
0
4769
30.44
A
11986
D
Common Stock
2020-08-12
4
M
0
4769
20
A
16755
D
Common Stock
2020-08-12
4
S
0
15047
77.14
D
1708
D
Common Stock
2020-08-13
4
S
0
86
79.62
D
1622
D
Restricted Stock Units
2020-08-11
4
A
0
208
0
A
Common Stock
208.0
208
D
Restricted Stock Units
2020-08-11
4
M
0
208
0
D
Common Stock
208.0
0
D
Employee Stock Option (Right to Buy)
20.0
2020-08-11
4
M
0
741
0
D
2026-08-02
Common Stock
741.0
5509
D
Employee Stock Option (Right to Buy)
30.44
2020-08-11
4
M
0
700
0
D
2027-07-07
Common Stock
700.0
11019
D
Employee Stock Option (Right to Buy)
20.0
2020-08-11
4
M
0
700
0
D
2026-12-06
Common Stock
700.0
7894
D
Employee Stock Option (Right to Buy)
20.0
2020-08-12
4
M
0
5509
0
D
2026-08-02
Common Stock
5509.0
0
D
Employee Stock Option (Right to Buy)
30.44
2020-08-12
4
M
0
4769
0
D
2027-07-07
Common Stock
4769.0
6250
D
Employee Stock Option (Right to Buy)
20.0
2020-08-12
4
M
0
4769
0
D
2026-12-06
Common Stock
4769.0
3125
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.01 to $76.09, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $76.64 to $77.58, inclusive.
Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs granted on August 11, 2020.
Fully vested.
This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The options becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
/s/ Kirk Somers, Attorney-in-Fact
2020-08-13